Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study
CA19-9 is a tumor marker for pancreatic cancer (PC), and the nondiabetic cut-off level is 37 U/mL. CA19-9 levels are said to rise in patients with tumors like PC and intraductal papillary mucinous neoplasm (IPMN). CA19-9 levels have also been shown to be related to HbA1c levels. We hypothesized that...
Saved in:
Main Authors: | Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2023-11-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0186/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma
by: Jane J. Cheng, et al.
Published: (2025-02-01) -
High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients
by: Shouwen Wang, et al.
Published: (2025-01-01) -
Aptamer-Conjugated Multi-Quantum Dot-Embedded Silica Nanoparticles for Lateral Flow Immunoassay
by: Kwanghee Yoo, et al.
Published: (2025-01-01) -
Highly efficient assessment and selective determination of pancreatic cancer biomarker CA-19-9 using co-electrodeposited MXene-AgNPs nanocomposite
by: Mahsa Mirzayi, et al.
Published: (2025-02-01) -
Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retrospective Analysis
by: Makoto Kadokura, et al.
Published: (2023-04-01)